title: Is the increase in LDL cholesterol induced by selective serotonin reuptake inhibitor therapy a blessing in disguise?
authors.forename: Mark R
authors.initials: MR
authors.lastname: Goldstein
authors.forename: Luca
authors.initials: L
authors.lastname: Mascitelli
authors.forename: Francesca
authors.initials: F
authors.lastname: Pezzetta
mesh_terms: D000339:Affect / Q000187:drug effects; D000924:Anticholesteremic Agents / Q000009:adverse effects; D008078:Cholesterol, LDL / Q000097:blood*; D003863:Depression / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006801:Humans; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors